Weihai Baihe Biotechnology Co., Ltd
IPO online roadshow announcement
Sponsor (lead underwriter): Gf Securities Co.Ltd(000776)
Weihai Baihe Biotechnology Co., Ltd. (hereinafter referred to as “the issuer”) has obtained the approval of the CSRC’s zjxk (2022) No. 36 document for its application for initial public offering of no more than 16 million common shares (A shares) (hereinafter referred to as “the offering”). The sponsor (lead underwriter) of this offering is Gf Securities Co.Ltd(000776) (hereinafter referred to as “sponsor (lead underwriter)”). This offering is conducted by direct pricing online to social public investors holding non restricted A-Shares and non restricted depositary receipts in Shanghai market with a certain market value (hereinafter referred to as “online offering”), without offline inquiry and placement. The issue price is 42.14 yuan / share. The issuance scale is 16 million shares, of which 16 million shares are issued online, accounting for 100% of the total issuance. All the shares issued this time are new shares, and the transfer of old shares is not arranged. The shares issued this time have no circulation restrictions and locking arrangements.
In order to facilitate investors to understand the relevant situation and development prospect of the issuer and the relevant arrangements for subscription of this issuance, the issuer and the sponsor (lead underwriter) of this issuance will hold an online roadshow on this issuance. Please pay attention to it.
1. Online roadshow time: 14:00-17:00 on January 13, 2022 (Thursday, t-1)
2. Online roadshow website: Shanghai Securities roadshow Center: http://roadshow.sseinfo.com.
China Securities Network: http://roadshow.cn.stock.com.
3. Participants: key members of the issuer’s management and relevant personnel of the sponsor (lead underwriter)
The summary of IPO prospectus of Weihai Lily Biotechnology Co., Ltd. was published in China Securities Journal, Shanghai Securities News, securities times and Securities Daily on January 12, 2022 (T-2). The full text of the prospectus and documents for future reference can be found on the website of Shanghai Stock Exchange（ http://www.sse.com.cn. ）Query.
Please pay attention to it.
Issuer: sponsor (lead underwriter) of Weihai Lily Biotechnology Co., Ltd.: Gf Securities Co.Ltd(000776) January 12, 2022
